Wang Laboratories

Prilenia Expands Leadership Team, Appoints Anne Sullivan as Chief Business Officer

Retrieved on: 
Thursday, September 29, 2022
Neurology, Biotechnology, Pharmaceutical, Managed Care, General Health, Health, Clinical Trials, Other Health, Therapy, Talisman, College, Corporation, Lists of diseases, LLC, Neurodegeneration, Tuck School of Business, Company, Wang Laboratories, Senior, Acquisition, Business, Laboratory, CEO, Holy Cross, MBA, Dartmouth College, Founder, KPMG, Neurology, Alkermes (company), ALS, HD, Corporate development, Multimedia, CBO, Pharmaceutical industry, Management

Prilenia Therapeutics B.V. , a clinical stage biotechnology company focused on the urgent mission to develop novel therapeutics to slow the progression of neurodegenerative and neurodevelopmental disorders, today announced the appointment of Anne Sullivan as Chief Business Officer.

Key Points: 
  • Prilenia Therapeutics B.V. , a clinical stage biotechnology company focused on the urgent mission to develop novel therapeutics to slow the progression of neurodegenerative and neurodevelopmental disorders, today announced the appointment of Anne Sullivan as Chief Business Officer.
  • View the full release here: https://www.businesswire.com/news/home/20220928006018/en/
    Anne Sullivan, Chief Business Officer at Prilenia (Photo: Business Wire)
    As Prilenia prepares for key milestones in its pipeline over the coming months, we believe Anne brings tremendous experience and perspective to our leadership team, said Dr. Michael R. Hayden, CEO and Founder of Prilenia.
  • Prilenia represents an organization truly committed to scientific rigor as well as to people living with serious neurological diseases, like Huntingtons disease and ALS, and I couldnt be more pleased to join the team and advance its mission, said Anne Sullivan, Chief Business Officer at Prilenia.
  • Prior to joining Prilenia, Anne served as Chief Business Officer at Rodin Therapeutics, a privately held clinical stage biopharmaceutical company discovering and developing first-in-class therapeutics for serious neurological diseases.

Chatham Lodging Enhances Board with Appointment of Two Trustees

Retrieved on: 
Tuesday, August 10, 2021
Professional Services, Other Travel, Other Construction & Property, Lodging, Commercial Building & Real Estate, Destinations, Construction & Property, Travel, Other Professional Services, REIT, Finance, Consulting, Loyola University, Trustee, Industry, Michigan State University, Food, REIT, FPL, Marriott International, Bop TV, Analysis, John Greenwood (racing driver), NextEra Energy, U.S. Securities and Exchange Commission, Parliamentary Information Technology Committee, AT&T Mobility, Loyola University Chicago, Security (finance), Wang Laboratories, Risk, NYSE, Audit committee, Regis Corporation, Forward-looking statement, Financial condition report, Annual report, Mission statement, Edition, Nova Southeastern University, IBM, Engineering, District, Group, Board, Florida Power & Light, Leadership, AT, George Washington University, Government, Golf, Marketing, Financial management, Conversation, Result, Hotel, Management

Chatham Lodging Trust (NYSE: CLDT), a lodging real estate investment trust (REIT) that invests in upscale, extended-stay hotels and premium-branded, select-service hotels and owns 41 hotels, today announced the appointment of Ethel Isaacs Williams and David J. Grissen to the company's board of trustees, effective immediately.

Key Points: 
  • Chatham Lodging Trust (NYSE: CLDT), a lodging real estate investment trust (REIT) that invests in upscale, extended-stay hotels and premium-branded, select-service hotels and owns 41 hotels, today announced the appointment of Ethel Isaacs Williams and David J. Grissen to the company's board of trustees, effective immediately.
  • These new additions will further strengthen the leadership expertise, skillsets and diversity represented on the companys board of trustees as the company strives to create value for all stakeholders.
  • Mr. Grissen joins Chathams board after having recently retired as group president following a stellar 35-year career at Marriott International, Inc.
  • Chatham Lodging Trust is a self-advised, publicly-traded real estate investment trust focused primarily on investing in upscale, extended-stay hotels and premium-branded, select-service hotels.